How Much Does Provigil Cost in Vermont in 2026?

Brand vs. Generic Pricing in Vermont

The price gap between brand Provigil and generic modafinil remains enormous. Cephalon's brand product carries a wholesale acquisition cost near $850 for a 30-day supply of 200 mg tablets. Generic modafinil, available from manufacturers including Teva, Mylan, and Aurobindo, averages approximately $80 per month at Vermont retail pharmacies without insurance.

This price differential reflects a pattern seen across the generic drug market. The FDA's Office of Generic Drugs approved the first generic modafinil formulations in 2012, and competition among manufacturers has driven cash prices down by more than 90% from the original brand cost. Vermont pharmacies, including chains like CVS, Walgreens, Kinney Drugs, and independent retailers, generally price generic modafinil between $60 and $110 for 30 tablets depending on the specific manufacturer stocked.

Prices vary by pharmacy location within Vermont. Burlington-area pharmacies tend to cluster near the $75-$85 range, while rural pharmacies in the Northeast Kingdom or Southern Vermont sometimes price slightly higher due to lower prescription volume and different wholesaler contracts. Calling ahead or using a price comparison tool before filling can save $15-$30 on the same prescription.

The original US Modafinil in Narcolepsy Multicenter Study Group trial (Ann Neurol 1998, N=283) established that modafinil 200 mg and 400 mg both significantly reduced daytime sleepiness compared to placebo, with the 200 mg dose offering equivalent efficacy and fewer side effects. This finding means most patients can achieve therapeutic benefit at the lower, less expensive dose.

Vermont Medicaid Coverage

Vermont Medicaid, administered through the Department of Vermont Health Access (DVHA), covers generic modafinil with prior authorization. The PA requirement exists because modafinil is a Schedule IV controlled substance and because the program requires documentation of an FDA-approved indication before covering the prescription.

To obtain PA approval, prescribers must document one of three diagnoses: narcolepsy, obstructive sleep apnea (as adjunct to CPAP), or shift work disorder. The prescriber submits clinical notes confirming the diagnosis, typically including a sleep study for narcolepsy or OSA, or documentation of a qualifying shift schedule for shift work disorder.

Approval timelines run 24-72 hours for standard requests. Urgent requests for established patients can receive same-day decisions. Once approved, Vermont Medicaid generally covers modafinil at a $0-$3 copay for most enrollees. The Endocrine Society's clinical practice guidelines reference wakefulness-promoting agents within broader fatigue management frameworks, supporting their medical necessity for approved conditions.

Vermont's Medicaid formulary reviews occur quarterly. As of early 2026, generic modafinil maintains its position as a covered drug without step therapy requirements, meaning patients do not need to try and fail another medication first. This is notable because some state Medicaid programs require a trial of cheaper alternatives like caffeine-based preparations before authorizing modafinil.

Commercial Insurance Coverage in Vermont

The three largest commercial insurers operating in Vermont (Blue Cross Blue Shield of Vermont, MVP Health Care, and Cigna) all include generic modafinil on their formularies. Placement and cost-sharing differ by plan tier.

Blue Cross Blue Shield of Vermont places generic modafinil on Tier 2 (preferred generic) for most plans, with copays ranging from $15 to $35. Some high-deductible health plans require the member to pay the full negotiated price (typically $40-$65) until the deductible is met.

MVP Health Care covers modafinil on Tier 2 with prior authorization required regardless of indication. Copays range from $10 to $30 depending on the specific plan purchased through Vermont Health Connect or employer groups.

Cigna formularies in Vermont typically place modafinil on Tier 2 with a $20-$45 copay. PA requirements apply for new prescriptions but not for established patients with documented refill history.

According to the FDA-approved prescribing information for Provigil, the drug carries indications for three conditions only: narcolepsy, shift work disorder, and residual sleepiness in obstructive sleep apnea despite adequate CPAP use. Insurance coverage generally tracks these indications. Off-label use for conditions such as ADHD, fatigue in multiple sclerosis, or cognitive enhancement will likely result in a PA denial unless the prescriber provides compelling clinical justification.

Dr. Michael Thorpy, Director of the Sleep-Wake Disorders Center at Montefiore Medical Center, has stated: "Modafinil remains a first-line therapy for excessive daytime sleepiness in narcolepsy, with a safety profile established over more than two decades of clinical use."

Discount Programs and Savings Cards

Several pathways exist to reduce modafinil costs for Vermont residents who are uninsured, underinsured, or facing high copays.

Manufacturer savings programs. Teva and other generic manufacturers occasionally offer copay assistance cards that reduce the out-of-pocket cost to $0-$25 for commercially insured patients. These programs exclude government insurance beneficiaries (Medicaid, Medicare, Tricare). Availability changes quarterly; check directly with the dispensing pharmacy.

Pharmacy discount platforms. GoodRx, RxSaver, and SingleCare all provide coupons accepted at Vermont pharmacies. Typical discounted prices for 30 tablets of modafinil 200 mg fall between $25 and $60, depending on the specific pharmacy and current offers. These coupons cannot be combined with insurance but often beat the insurance copay for patients on high-deductible plans.

Vermont-specific programs. The Vermont Health Connect marketplace plans must cover prescription drugs as an essential health benefit under the ACA. Residents earning between 138% and 400% of the federal poverty level may qualify for premium subsidies and cost-sharing reductions that lower prescription copays. The CDC's prescription assistance resource page provides broader guidance on navigating coverage pathways.

340B pricing. Federally Qualified Health Centers (FQHCs) in Vermont, including Community Health Centers of Burlington and Northern Counties Health Care, access 340B drug pricing. Patients seen at these clinics may receive modafinil at significantly reduced cost, sometimes under $20 for a 30-day supply, regardless of insurance status.

Compounded Modafinil in Vermont

Compounded modafinil is legal in Vermont through licensed 503A compounding pharmacies. A 503A pharmacy compounds medications pursuant to individual patient prescriptions, as distinct from 503B outsourcing facilities that produce larger batches without patient-specific prescriptions.

Vermont's Board of Pharmacy regulates compounding pharmacies under state law aligned with FDA guidelines established in the Drug Quality and Security Act. Compounded modafinil may be prescribed when a patient has a documented medical need that commercial products cannot meet. Examples include allergy to inactive ingredients in manufactured tablets, need for a non-standard dose, or requirement for an alternative dosage form such as a liquid suspension.

Pricing for compounded modafinil varies significantly. Some compounding pharmacies offer 30-day supplies at cost-competitive rates, though quality and bioavailability may differ from FDA-approved manufactured tablets. Patients considering compounded modafinil should verify their pharmacy holds current Vermont Board of Pharmacy compounding licensure and follows USP 795 standards for non-sterile compounding.

A Cochrane systematic review of modafinil for excessive daytime sleepiness in narcolepsy confirmed that modafinil at standard doses reduces sleepiness scores on the Epworth Sleepiness Scale by approximately 3-4 points versus placebo, an effect size considered clinically meaningful. This evidence base applies specifically to manufactured, bioequivalent formulations. Compounded versions have not undergone the same bioequivalence testing.

Telehealth Prescribing in Vermont

Vermont permits telehealth prescribing of modafinil under current state regulations. The state's telehealth parity law, updated during the COVID-19 pandemic and made permanent in subsequent legislative sessions, allows providers to prescribe Schedule IV controlled substances via audio-video consultation without requiring an in-person visit.

Several telehealth platforms serve Vermont residents for sleep disorder management. Prescribers must hold an active Vermont medical license or practice under an interstate compact agreement. The NIH's National Institute of Neurological Disorders and Stroke maintains patient information on narcolepsy and hypersomnia that can help patients prepare for telehealth consultations.

For the initial prescription, most telehealth providers require:

• Documentation of a sleep disorder diagnosis (prior sleep study, referring physician notes, or clinical assessment during the telehealth visit)
• Review of current medications for interaction screening
• Discussion of the controlled substance agreement
• Vermont residency verification

Refills via telehealth are straightforward once the initial prescription is established. Vermont law does not impose a limit on consecutive telehealth visits for ongoing management of the same condition, meaning patients can maintain their modafinil prescription entirely through virtual care if clinically appropriate.

The American Academy of Sleep Medicine's position statement notes: "Telehealth has demonstrated equivalent patient satisfaction and clinical outcomes for ongoing sleep disorder management compared to in-person visits, particularly for medication management of established diagnoses."

How Modafinil Compares to Alternatives on Cost

Vermont residents weighing modafinil against other wakefulness-promoting agents should consider both clinical efficacy and out-of-pocket cost.

Armodafinil (Nuvigil generic): The R-enantiomer of modafinil, priced similarly at $70-$100 per month for generic versions in Vermont. Insurance coverage mirrors modafinil. Some patients report longer duration of action, though head-to-head data published in the Annals of Internal Medicine show no significant efficacy difference for most patients.

Solriamfetol (Sunosi): A newer dopamine-norepinephrine reuptake inhibitor approved for narcolepsy and OSA sleepiness. No generic available in 2026. Cash price exceeds $500/month. Insurance coverage requires step therapy through modafinil/armodafinil first in most Vermont plans.

Pitolisant (Wakix): A histamine H3 receptor inverse agonist for narcolepsy. Branded only, priced above $8,000/month without insurance. Covered by some Vermont commercial plans after step therapy failure.

Methylphenidate and amphetamine-based stimulants: Schedule II controlled substances with stricter prescribing requirements. Generic prices range from $20-$60/month but carry higher abuse potential and cardiovascular monitoring requirements.

For most Vermont patients with insurance, generic modafinil represents the best balance of efficacy, safety, cost, and prescribing convenience. The National Institutes of Health clinical trials database lists ongoing studies comparing newer agents to modafinil, but no trial to date has demonstrated sufficient superiority to justify the higher cost of branded alternatives as first-line therapy.

Tips for Minimizing Your Cost in Vermont

Practical steps to reduce what you pay for modafinil in Vermont:

1. Always request generic. Specify "modafinil" rather than "Provigil" to avoid inadvertent brand dispensing. Vermont's generic substitution law permits pharmacists to substitute automatically unless the prescriber writes "brand medically necessary."

2. Compare pharmacy prices before filling. A single phone call to three pharmacies often reveals a $20-$40 price difference for the same generic product.

3. Ask about 90-day supplies. Many Vermont pharmacies and mail-order services offer a 90-day supply at 2.0-2.5x the 30-day price, saving 17-33% over three monthly fills.

4. Stack discount coupons against your copay. If your insurance copay exceeds the GoodRx or SingleCare discounted price, pay cash with the coupon instead. This does not count toward your deductible but saves immediate dollars.

5. Consider pill splitting for the 200 mg dose. If prescribed 200 mg, buying 400 mg tablets and splitting them can cut cost by 30-40%. Modafinil tablets are scored and suitable for splitting. Confirm with your pharmacist.

6. Check FQHC eligibility. Community health centers in Vermont offer sliding-scale fees and 340B drug pricing. You do not need to be uninsured to qualify; underinsured patients also benefit.

According to data from the Agency for Healthcare Research and Quality, prescription cost remains the most common reason for medication non-adherence among patients with sleep disorders. Taking fifteen minutes to compare pricing options often saves hundreds of dollars annually.